Clinical Trial Results:
Safety, Tolerability and Pharmacokinetics of 3 Dose regimens of AZD1446
vs. Placebo as an Add-on Treatment to Donepezil:
A Multi-centre, Double-blind, Randomised, Placebo controlled, Parallel
group Phase IIa Study in Patients with Mild to Moderate Alzheimer’s
Disease during 4 weeks of Treatment
Summary
|
|
EudraCT number |
2009-015525-37 |
Trial protocol |
HU CZ SK |
Global completion date |
01 Jul 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
21 Sep 2016
|
First version publication date |
21 Sep 2016
|
Other versions |
|
Summary report(s) |
D1950C00006-CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.